FDA Action AlertAcromegaly, Blockbusters, Checkpoint Inhibitors, Clinical Trials, Cutaneous Squamous Cell Carcinoma (CSCC), Diffuse Large B-Cell Lymphoma (DLBCL), Dravet syndrome, FDA/Regulatory, NDA Resubmission, New Drug Applications, Non-alcoholic steatohepatitis (NASH), Postoperative Pain, R&D, Seizures, Supplemental Biologics License Application, Supplemental New Drug Application (sNDA), TherapeuticsWrapping up June and ahead of the July 4 holiday, the U.S. Food and Drug Administration has a busy two-week period coming up for drug approval reviews. Read more June 22, 2020/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/06/FDA-Action-Alert-Karyopharm-Zogenix-Chiasma-Heron-Intercept-and-Merck-BioSpace-6-22-20.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2020-06-22 12:25:222020-07-07 18:05:43FDA Action Alert